A society based research to assess adherence of antiretroviral therapy

Authors

  • Smarajit Jana Principal Sonagachi Research and Training Institute 44 Balaram Dey Street Kolkata 700006, India
  • Protim Ray Sr. Medical Officer Sonagachi Research and Training Institute Kolkata, India
  • Krishnangshu Roy Director Institute of Health & Family Welfare Govt. of West Bengal Kolkata 700091, India
  • Debashis Mandal Hon. Senior Lecturer University of Manchester Consultant Physician in Genitourinary Medicine Warrington & Halton

Keywords:

ART, Network, Adherence, HIV Individuals

Abstract

Access Adherence to Antiretroviral Therapy. A community-based antiretroviral (ART) drugs adherence study was conducted in Kolkata, India beginning in January and concluding in March 2011. This study was designed to explore the level of adherence as well as factors influencing adherence to ART by those who are receiving treatment through a public health care delivery system. This health care system is implemented through the National AIDS Control Program in the state of West Bengal, India. The research findings showed a high degree of non-adherence, between 48-52%, among the ART recipients. The analysis highlights a number of key factors negatively influencing adherence including long waiting time at the ART center, distance from residence to ART Centre, travel related expenditure, and fear of being identified as HIV + to family members and neighbors. Some positive influences were identified in the data as well. If a person is a member of a positive people network there is a greater chance for adherence as well as if an individual self-identifies as positive to others. However, no single factor, rather a combination of several factors, proved to be responsible for influencing ART adherence among recipients.  

Downloads

Download data is not yet available.

References

Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., ... & Schoenbaum, E. E. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clinical infectious diseases, 33(8), 1417-1423.
Bangsberg, D. R. (2006). Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical infectious diseases, 43(7), 939-941.
Bangsberg, D. R. (2008). Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. The Journal of infectious diseases, 197(Supplement_3), S272-S278.
Bangsberg, D. R., Charlebois, E. D., Grant, R. M., Holodniy, M., Deeks, S. G., Perry, S., ... & Moss, A. (2003). High levels of adherence do not prevent accumulation of HIV drug resistance mutations. Aids, 17(13), 1925-1932.
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., ... & Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. Aids, 14(4), 357-366.
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., ... & Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. Aids, 14(4), 357-366.
Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., & Moss, A. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. Aids, 15(9), 1181-1183.
Castilla, J., Del Romero, J., Hernando, V., Marincovich, B., García, S., & Rodríguez, C. (2005). Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes, 40(1), 96-101.
Cauldbeck, M. B., O'Connor, C., O'Connor, M. B., Saunders, J. A., Rao, B., Mallesh, V. G., ... & Satish, K. S. (2009). Adherence to anti-retroviral therapy among HIV patients in Bangalore, India. AIDS research and therapy, 6(1), 7.
Chakrapani, V., Newman, P. A., Shunmugam, M., Kurian, A. K., & Dubrow, R. (2009). Barriers to free antiretroviral treatment access for female sex workers in Chennai, India. AIDS patient care and STDs, 23(11), 973-980.
Erickson, S. R., Ascione, F. J., Kirking, D. M., & Johnson, C. E. (1998). Use of a paging system to improve medication self-management in patients with asthma. Journal of the American Pharmacists Association, 38(6), 767-769.
Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient education and counseling, 46(2), 93-108.
Gardner, E. M., Hullsiek, K. H., Telzak, E. E., Sharma, S., Peng, G., Burman, W. J., ... & Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA. (2010). Antiretroviral medication adherence and class-specific resistance in a large prospective clinical trial. AIDS (London, England), 24(3), 395.
Gross, R., Bilker, W. B., Friedman, H. M., Coyne, J. C., & Strom, B. L. (2002). Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. Aids, 16(13), 1835-1837.
Gulick, R. M. (2006). Adherence to antiretroviral therapy: how much is enough?.
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979). Compliance in health care.
Hoffmann, C., & Mulcahy, F. (2006). Overview of antiretroviral agents. HIV medicine 14th edition. Hoffmann C, Rockstroh JK, Kamps BS (editors). Paris: Flying Publisher, 94-130.
Johnson, M. O., Charlebois, E., Morin, S. F., Catz, S. L., Goldstein, R. B., Remien, R. H., ... & Lightfoot, M. A. (2005). Perceived adverse effects of antiretroviral therapy. Journal of pain and symptom management, 29(2), 193-205.
Maggiolo, F., Airoldi, M., Kleinloog, H. D., Callegaro, A., Ravasio, V., Arici, C., ... & Suter, F. (2007). Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-treated patients. HIV clinical trials, 8(5), 282-292.
Malta, M., Magnanini, M. M., Strathdee, S. A., & Bastos, F. I. (2010). Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS and Behavior, 14(4), 731-747.
Mannheimer, S., Thackeray, L., Huppler Hullsiek, K., Chesney, M., Gardner, E. M., Wu, A. W., ... & Terry Beirn Community Program for Clinical Research on AIDS. (2008). A randomized comparison of two instruments for measuring self-reported antiretroviral adherence. AIDS care, 20(2), 161-169.
Mills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., ... & Cooper, C. (2006). Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS medicine, 3(11), e438.
Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., ... & Wilson, K. (2006). Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. Jama, 296(6), 679-690.
Montaner, J. S., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., ... & Myers, M. (1998). A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Jama, 279(12), 930-937.
Paasche?Orlow, M. K., Cheng, D. M., Palepu, A., Meli, S., Faber, V., & Samet, J. H. (2006). Health literacy, antiretroviral adherence, and HIV?RNA suppression: a longitudinal perspective. Journal of General Internal Medicine, 21(8), 835-840.
Parienti, J. J., Massari, V., Descamps, D., Vabret, A., Bouvet, E., Larouzé, B., & Verdon, R. (2004). Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine-or efavirenz-based antiretroviral therapy. Clinical Infectious Diseases, 38(9), 1311-1316.
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., ... & Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of internal medicine, 133(1), 21-30.
Porco, T. C., Martin, J. N., Page-Shafer, K. A., Cheng, A., Charlebois, E., Grant, R. M., & Osmond, D. H. (2004). Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS (London, England), 18(1), 81.
Protopopescu, C., Raffi, F., Roux, P., Reynes, J., Dellamonica, P., Spire, B., ... & ANRS CO8 (APROCO-COPILOTE) Study Group. (2009). Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data. Journal of Antimicrobial Chemotherapy, 64(3), 599-606.
Rueda, S., Park?Wyllie, L. Y., Bayoumi, A., Tynan, A. M., Antoniou, T., Rourke, S., & Glazier, R. (2006). Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. The Cochrane Library.
Sethi, A. K., Celentano, D. D., Gange, S. J., Moore, R. D., & Gallant, J. E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases, 37(8), 1112-1118.
Simoni, J. M., Pearson, C. R., Pantalone, D. W., Marks, G., & Crepaz, N. (2006). Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a meta-analytic review of randomized controlled trials. Journal of acquired immune deficiency syndromes (1999), 43(0 1), S23.
Turner, B. J. (2002). Adherence to antiretroviral therapy by human immunodeficiency virus—infected patients. The Journal of Infectious Diseases, 185(Supplement_2), S143-S151.
Walsh, J. C., Pozniak, A. L., Nelson, M. R., Mandalia, S., & Gazzard, B. G. (2002). Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance. Journal of acquired immune deficiency syndromes (1999), 30(3), 278-287.
Ware, N. C., Wyatt, M. A., & Tugenberg, T. (2006). Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS care, 18(8), 904-910.
Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'shaughnessy, M. V., & Montaner, J. S. (2004). The impact of adherence on CD4 cell count responses among HIV-infected patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 35(3), 261-268.

Published

2015-12-31

How to Cite

Jana, S., Ray, P., Roy, K., & Mandal, D. (2015). A society based research to assess adherence of antiretroviral therapy. International Research Journal of Engineering, IT & Scientific Research, 1(1), 1–11. Retrieved from https://sloap.org/journals/index.php/irjeis/article/view/233

Issue

Vol. 1 No. 1: December 2015

Section

Research Articles
Copyright & Licensing

Articles published in the International Research Journal of Engineering, IT & Scientific research (IRJEIS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IRJEIS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.

Articles published in IRJEIS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

This copyright notice applies to articles published in IRJEIS volumes 6 onwards. Please read about the copyright notices for previous volumes under Journal History.